Skip to main content
Top
Published in: Cardiovascular Intervention and Therapeutics 4/2019

01-10-2019 | Computed Tomography | Original Article

Utility of preprocedural multidetector computed tomography in alcohol septal ablation for hypertrophic obstructive cardiomyopathy

Authors: Takashi Yanagiuchi, Norio Tada, Yoshihiro Haga, Shinichi Suzuki, Mie Sakurai, Masataka Taguri, Tatsushi Ootomo

Published in: Cardiovascular Intervention and Therapeutics | Issue 4/2019

Login to get access

Abstract

Preprocedural computed tomography (CT) imaging appears to provide an advantage in localization of the appropriate septal branch targeted for alcohol septal ablation (ASA). The objective of this study was to compare the clinical backgrounds, procedural characteristics, and outcomes of patients who underwent ASA with preprocedural CT assessment against those without CT assessment. Thirty consecutive patients with obstructive hypertrophic cardiomyopathy who underwent ASA were retrospectively included. Patients who underwent preprocedural CT (CT-guided ASA group, n = 11) were compared with patients who underwent ASA without CT (traditional ASA group, n = 19). The CT-guided ASA group had a significantly lower number of approached target vessels (1 [interquartile range {IQR}, 1–2] vs. 2 [IQR, 2–3], P = 0.036) and non-ablated target vessels (0 [IQR, 0–1] vs. 1 [IQR, 0–2], P = 0.031) than the traditional ASA group. There were no differences between the two groups in total fluoroscopy time, the amount of delivered radiation dose, and the volume of contrast medium used during the procedures. There were also no differences between the two groups in procedural success rate and improvement of left ventricular outflow tract gradient and New York Heart Association functional class at 1 month follow-up. CT had a significant impact on the ASA procedure diminishing the number of target vessels, and could be a reliable assessment modality to build its procedural strategy.
Literature
1.
go back to reference Agarwal S, Tuzcu EM, Desai MY, Smedira N, Lever HM, Lytle BW, et al. Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010;55:823–34.CrossRefPubMed Agarwal S, Tuzcu EM, Desai MY, Smedira N, Lever HM, Lytle BW, et al. Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010;55:823–34.CrossRefPubMed
2.
go back to reference Alam M, Dokainish H, Lakkis NM. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis. Eur Heart J. 2009;30:1080–7.CrossRefPubMed Alam M, Dokainish H, Lakkis NM. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis. Eur Heart J. 2009;30:1080–7.CrossRefPubMed
3.
go back to reference Sorajja P, Ommen SR, Homes DR Jr, Dearani JA, Rihal CS, Gersh BJ, et al. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2012;126:2374–80.CrossRefPubMed Sorajja P, Ommen SR, Homes DR Jr, Dearani JA, Rihal CS, Gersh BJ, et al. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2012;126:2374–80.CrossRefPubMed
4.
go back to reference Leonardi RA, Kransdorf EP, Simel DL, Wang A. Meta-analysis of septal reduction therapies for obstructive hypertrophic cardiomyopathy. Comparative rates of overall mortality and sudden cardiac death after treatment. Circ Cardiovasc Interv. 2010;3:97–104.CrossRefPubMed Leonardi RA, Kransdorf EP, Simel DL, Wang A. Meta-analysis of septal reduction therapies for obstructive hypertrophic cardiomyopathy. Comparative rates of overall mortality and sudden cardiac death after treatment. Circ Cardiovasc Interv. 2010;3:97–104.CrossRefPubMed
5.
go back to reference Jensen MK, Prinz C, Horsthotte D, van Buuren F, Bitter T, Faber L, et al. Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile. Heart. 2013;99:1012–7.CrossRefPubMed Jensen MK, Prinz C, Horsthotte D, van Buuren F, Bitter T, Faber L, et al. Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile. Heart. 2013;99:1012–7.CrossRefPubMed
6.
go back to reference Yoerger DM, Picard MH, Palacios IF, Vlahakes GJ, Lowry PA, Fifer MA. Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2006;97:1511–4.CrossRefPubMed Yoerger DM, Picard MH, Palacios IF, Vlahakes GJ, Lowry PA, Fifer MA. Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2006;97:1511–4.CrossRefPubMed
7.
go back to reference Chang SM, Lakkis NM, Franklin J, Spencer WH 3rd, Nagueh SF. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Circulation. 2004;109:824–7.CrossRefPubMed Chang SM, Lakkis NM, Franklin J, Spencer WH 3rd, Nagueh SF. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Circulation. 2004;109:824–7.CrossRefPubMed
8.
go back to reference ten Cate FJ, Soliman OII, Michels M, Theuns DA, de Jong PL, Geleijnse ML, et al. Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardio myopathy. A word of caution. Circ Heart Fail. 2010;3:362–9.CrossRefPubMed ten Cate FJ, Soliman OII, Michels M, Theuns DA, de Jong PL, Geleijnse ML, et al. Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardio myopathy. A word of caution. Circ Heart Fail. 2010;3:362–9.CrossRefPubMed
9.
go back to reference Veselka J, Prochazkova S, Duchonova R, Bolomova-Homolova I, Palenickova J, Tesar D, et al. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome. Catheter Cardiovasc Interv. 2004;63:231–5.CrossRefPubMed Veselka J, Prochazkova S, Duchonova R, Bolomova-Homolova I, Palenickova J, Tesar D, et al. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome. Catheter Cardiovasc Interv. 2004;63:231–5.CrossRefPubMed
10.
go back to reference Heldman AW, Wu KC, Abraham TP, Cameron DE. Myectomy or alcohol septal ablation. Surgery and percutaneous intervention go another round. J Am Coll Cardiol. 2007;49:358–60.CrossRefPubMed Heldman AW, Wu KC, Abraham TP, Cameron DE. Myectomy or alcohol septal ablation. Surgery and percutaneous intervention go another round. J Am Coll Cardiol. 2007;49:358–60.CrossRefPubMed
11.
go back to reference Krishnaswamy A, Tuzcu EM, Kapadia SR. Use of intra-procedural CT imaging to guide alcohol septal ablation of hypertrophic cardiomyopathy in the cardiac catheterization laboratory. Catheter Cardiovasc Interv. 2012;80:991–4.CrossRefPubMed Krishnaswamy A, Tuzcu EM, Kapadia SR. Use of intra-procedural CT imaging to guide alcohol septal ablation of hypertrophic cardiomyopathy in the cardiac catheterization laboratory. Catheter Cardiovasc Interv. 2012;80:991–4.CrossRefPubMed
12.
go back to reference Cooper RM, Binukrishnan SR, Shahzad A, Hasleton J, Sigwart U, Stables RH. Computed tomography angiography planning identifies the target vessel for optimum infarct location and improves clinical outcome in alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Eurointervention. 2017;12:e2194–203.CrossRefPubMed Cooper RM, Binukrishnan SR, Shahzad A, Hasleton J, Sigwart U, Stables RH. Computed tomography angiography planning identifies the target vessel for optimum infarct location and improves clinical outcome in alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Eurointervention. 2017;12:e2194–203.CrossRefPubMed
13.
go back to reference Holmes DR Jr, Valeti US, Nishimura RA. Alcohol septal ablation for hypertrophic cardiomyopathy: indications and technique. Catheter Cardiovasc Interv. 2005;66:375–89.CrossRefPubMed Holmes DR Jr, Valeti US, Nishimura RA. Alcohol septal ablation for hypertrophic cardiomyopathy: indications and technique. Catheter Cardiovasc Interv. 2005;66:375–89.CrossRefPubMed
14.
go back to reference Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation. 1998;98:2415–21.CrossRefPubMed Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation. 1998;98:2415–21.CrossRefPubMed
15.
go back to reference van Dockum WG, ten Cate FJ, ten Berg JM, Beek AM, Twisk JW, Vos J, et al. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol. 2004;43:27–34.CrossRefPubMed van Dockum WG, ten Cate FJ, ten Berg JM, Beek AM, Twisk JW, Vos J, et al. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol. 2004;43:27–34.CrossRefPubMed
Metadata
Title
Utility of preprocedural multidetector computed tomography in alcohol septal ablation for hypertrophic obstructive cardiomyopathy
Authors
Takashi Yanagiuchi
Norio Tada
Yoshihiro Haga
Shinichi Suzuki
Mie Sakurai
Masataka Taguri
Tatsushi Ootomo
Publication date
01-10-2019
Publisher
Springer Japan
Published in
Cardiovascular Intervention and Therapeutics / Issue 4/2019
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-019-00574-0

Other articles of this Issue 4/2019

Cardiovascular Intervention and Therapeutics 4/2019 Go to the issue